Regarding antiinfection prophylaxis measures, both subgroups were comparable, 13 (26%) anti-MPO antibody-positive patients were vaccinated against flu and/or S. pneumoniae (4 in the low ceruloplasmin group and 9 in the high ceruloplasmin group). The gene discussed is MPO; the disease is influenza.